Masimo Corp., an Irvine-based medical device maker trying to broaden to the consumer market, claimed victory over Apple Inc. after a jury trial concluded today in Delaware.
“The jury found that Masimo did not infringe any of Apple’s technology patents, that one of Apple’s technology patent claims is invalid and that no current Masimo product infringed any of Apple’s design patents,” said a statement from Masimo.
“Although the jury found that a discontinued module and charger infringed two Apple design patents, it awarded Apple only $250.
“Apple primarily sought an injunction against Masimo’s current products, and the jury’s verdict is a victory for Masimo on that issue.”
An Apple spokesman said the jury found Masimo “willfully infringed Apple’s patented designs.
“Masimo took shortcuts, launching a device that copies Apple Watch and infringes our intellectual property,” Apple said. “We are glad the jury’s decision today will protect the innovations we advance on behalf of our customers.”
Shares of Masimo were unchanged after the verdict became known. During regular trading, the shares fell 1% to $139.33 and a $7.5 billion market cap.